Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Sponsor: Tela Bio Inc
Summary
This study is designed to evaluate the post-operative complications and hernia recurrence following the use of OviTex in subjects with ventral or inguinal hernias. Up to 160 subjects will participate in the study from up to 20 investigator sites.
Official title: A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2021-04-29
Completion Date
2027-12-30
Last Updated
2025-10-10
Healthy Volunteers
Yes
Conditions
Interventions
OviTex Reinforced Tissue Matrix
All study subjects will receive OviTex. All OviTex Reinforced Tissue Matrices are intended for use as a surgical mesh to reinforce or repair soft tissue where weakness exists.
Locations (10)
University of South Alabama
Mobile, Alabama, United States
SurgOne
Denver, Colorado, United States
GenesisCare
Destin, Florida, United States
Surgical Healing Arts Center
Fort Myers, Florida, United States
St. Luke's Hospital
Overland Park, Kansas, United States
University of Louisville
Louisville, Kentucky, United States
Munson Healthcare
Traverse City, Michigan, United States
St. Francis Hospital
Roslyn, New York, United States
Mohawk Valley Health System
Utica, New York, United States
Houston Methodist
Houston, Texas, United States